321 related articles for article (PubMed ID: 27700100)
1. Proteolysis by Granzyme B Enhances Presentation of Autoantigenic Peptidylarginine Deiminase 4 Epitopes in Rheumatoid Arthritis.
Darrah E; Kim A; Zhang X; Boronina T; Cole RN; Fava A; Giles JT; Bingham III CO; Chalmers MJ; Griffin PR; Sadegh-Nasseri S; Rosen A
J Proteome Res; 2017 Jan; 16(1):355-365. PubMed ID: 27700100
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases.
Umeda N; Matsumoto I; Kawaguchi H; Kurashima Y; Kondo Y; Tsuboi H; Ogishima H; Suzuki T; Kagami Y; Sakyu T; Ishigami A; Maruyama N; Sumida T
Clin Rheumatol; 2016 May; 35(5):1181-8. PubMed ID: 26415740
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.
Ferucci ED; Darrah E; Smolik I; Choromanski TL; Robinson DB; Newkirk MM; Fritzler MJ; Rosen A; El-Gabalawy HS
J Rheumatol; 2013 Sep; 40(9):1523-8. PubMed ID: 23908443
[TBL] [Abstract][Full Text] [Related]
5. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
Shi J; Darrah E; Sims GP; Mustelin T; Sampson K; Konig MF; Bingham CO; Rosen A; Andrade F
Ann Rheum Dis; 2018 Jan; 77(1):141-148. PubMed ID: 29070531
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
[TBL] [Abstract][Full Text] [Related]
7. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
9. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.
Navarro-Millán I; Darrah E; Westfall AO; Mikuls TR; Reynolds RJ; Danila MI; Curtis JR; ; Rosen A; Bridges SL
Arthritis Res Ther; 2016 Oct; 18(1):241. PubMed ID: 27770831
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
11. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis.
Zhao J; Zhao Y; He J; Jia R; Li Z
J Rheumatol; 2008 Jun; 35(6):969-74. PubMed ID: 18398945
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
14. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to PAD4 and BRAF in rheumatoid arthritis.
Auger I; Charpin C; Balandraud N; Martin M; Roudier J
Autoimmun Rev; 2012 Sep; 11(11):801-3. PubMed ID: 22349616
[TBL] [Abstract][Full Text] [Related]
16. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
17. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
[TBL] [Abstract][Full Text] [Related]
18. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
[TBL] [Abstract][Full Text] [Related]
19. Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate.
Pollmann S; Stensland M; Halvorsen EH; Sollid LM; Kvien TK; Fleckenstein B; Molberg O
Rheumatol Int; 2012 May; 32(5):1271-6. PubMed ID: 21267570
[TBL] [Abstract][Full Text] [Related]
20. Molecular Interplay between the Dimer Interface and the Substrate-Binding Site of Human Peptidylarginine Deiminase 4.
Lee CY; Lin CC; Liu YL; Liu GY; Liu JH; Hung HC
Sci Rep; 2017 Feb; 7():42662. PubMed ID: 28209966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
